CAH Insider Notice: 5,373 Common Shares Proposed Sale via Schwab

Rhea-AI Filing Summary

Cardinal Health (CAH) Form 144 notice reports a proposed sale of 5,373 common shares through The Charles Schwab Corporation on the NYSE with an aggregate market value of $795,204.00. The filer acquired the shares as restricted stock units on 08/16/2024 (3,050 shares) and 02/15/2025 (2,323 shares). The filing states there were 238,793,647 shares outstanding and lists the approximate sale date as 08/19/2025. No securities were reported sold by the filer in the past three months, and no gifts or noncash payments are indicated.

Insights

Securities Analyst

TL;DR: Routine insider sale notice of vested RSUs for a modest share amount relative to company float.

The Form 144 documents a proposed brokered sale of 5,373 common shares, acquired as restricted stock units on two dates in 2024 and 2025. The aggregate value reported is $795,204 against an outstanding share base of 238,793,647, indicating the sale represents an immaterial fraction of the companys shares outstanding. The filing does not report prior sales in the past three months and includes the standard representation about material nonpublic information. This appears to be a compliance disclosure for an insider selling vested equity rather than a material corporate event.

Corporate Governance Expert

TL;DR: Disclosure aligns with routine insider compliance; no governance red flags are evident in the notice.

The notice identifies the broker, proposed sale date, and acquisition details of the securities as restricted stock units issued by the company. The filer affirms absence of undisclosed material information and references Rule 10b5-1 plan provisions. There are no reported gifts, contingent payments, or recent sales to suggest unusual transfer arrangements. From a governance perspective, the filing meets procedural requirements for reporting proposed insider sales.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	The Charles Schwab Corporation 3000 Schwab Way Westlake TX 76262	5373	795204.00	238793647	08/19/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	08/16/2024	Restricted Stock Units	Issuer			3050	08/16/2024	N/A
Common	02/15/2025	Restricted Stock Units	Issuer			2323	02/15/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does Cardinal Health's (CAH) Form 144 report?

The Form 144 reports a proposed sale of 5,373 common shares through Charles Schwab with an aggregate market value of $795,204.00 and an approximate sale date of 08/19/2025.

How were the shares acquired that are being sold?

The shares were acquired as restricted stock units: 3,050 on 08/16/2024 and 2,323 on 02/15/2025.

Does the filing show recent sales by the filer in the past three months?

No. The filing indicates Nothing to Report for securities sold during the past three months by the filer.

What portion of Cardinal Health's shares outstanding does this sale represent?

The filing shows 238,793,647 shares outstanding; the proposed sale of 5,373 shares represents an immaterial fraction of that total based on the numbers provided.

Which broker is handling the proposed sale?

The broker named in the notice is The Charles Schwab Corporation located at 3000 Schwab Way, Westlake, TX.